ASPG and acute lymphoblastic leukemia: The prevalence of hyperglycemia during ALL therapy has been reported to be 10% to 20% during treatment with asparaginase and corticosteroids, most frequently in children above 10 years of age, with resolution after cessation or tapering down of these drugs112–116.